Sang-Yong Park
Directeur/Membre du Conseil chez GS GLOBAL CORP.
Profil
Sang-Yong Park is currently an Independent Director at GS Global Corp., a Director at Immunomic Therapeutics, Inc., and a Trustee at East Asia Institute.
He previously worked as the Chief Executive Officer at Macquarie Securities Korea Ltd.
Park received his graduate degree from The Trustees of Columbia University in The City of New York in 1992 and his undergraduate degree from the University of California in 1990.
Postes actifs de Sang-Yong Park
| Sociétés | Poste | Début |
|---|---|---|
| GS GLOBAL CORP. | Directeur/Membre du Conseil | 24/03/2017 |
Immunomic Therapeutics, Inc.
 Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Directeur/Membre du Conseil | 27/07/2021 |
| East Asia Institute | Directeur/Membre du Conseil | - |
Anciens postes connus de Sang-Yong Park
| Sociétés | Poste | Fin |
|---|---|---|
Macquarie Securities Korea Ltd.
 Macquarie Securities Korea Ltd. Investment Banks/BrokersFinance Macquarie Securities Korea Ltd. (MSKL) is the South Korean broker/dealer subsidiary of Great Britain-based Macquarie Internationale Investments Ltd., ultimately held by Macquarie Group Ltd. (ASX: MQG) in Australia. Headquartered in Seoul, MSKL was founded in 2006 and offers cash equities broking and risk and arbitrage trading services. | Directeur Général | - |
Formation de Sang-Yong Park
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| University of California | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GS GLOBAL CORP. | Distribution Services |
| Entreprise privées | 3 |
|---|---|
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Health Technology |
Macquarie Securities Korea Ltd.
Macquarie Securities Korea Ltd. Investment Banks/BrokersFinance Macquarie Securities Korea Ltd. (MSKL) is the South Korean broker/dealer subsidiary of Great Britain-based Macquarie Internationale Investments Ltd., ultimately held by Macquarie Group Ltd. (ASX: MQG) in Australia. Headquartered in Seoul, MSKL was founded in 2006 and offers cash equities broking and risk and arbitrage trading services. | Finance |
| East Asia Institute |
